Smruthi Organics hits 52-week high on receiving Brazilian GMP certificate for Unit II

Mumbai, November 12 (Udaipur Kiran): Smruthi Organics is currently trading at Rs. 180.75, up by 19.10 points or 11.82% from its previous closing of Rs. 161.65 on the BSE.

The scrip opened at Rs. 164.00 and has touched a high and low of Rs. 183.00 and Rs. 159.15 respectively. So far 28821 shares were traded on the counter.

The BSE group ‘X’ stock of face value Rs. 10 has touched a 52 week high of Rs. 183.00 on 12-Nov-2026 and a 52 week low of Rs. 95.00 on 01-Apr-2026.

Last one week high and low of the scrip stood at Rs. 183.00 and Rs. 141.00 respectively. The current market cap of the company is Rs. 200.48 crore.

The promoters holding in the company stood at 64.73%, while Non-Institutions held 35.27% stake in the company.

Smruthi Organics has received the Brazilian Good Manufacturing Practices (GMP) certificate (Certificado de Boas Praticas de Fabricagdo – CBPF) from the Brazilian Health Regulatory Agency (ANVISA) for the company’s Unit II situated at Chincholi, Solapur, Maharashtra. The certificate is valid up to October 26, 2028.

The certificate has been issued pursuant to Resolution RE No. 4,179 dated October 22, 2026, published in the Official Gazette of Brazil on October 26, 2026, certifying compliance with Good Manufacturing Practices in respect of the active pharmaceutical ingredient Levanlodipine Besylate Hemipentahydrate, manufactured at the company’s Unit.

Earlier, the company had received receipt of the inspection report dated October 8, 2026 issued by the ANVISA for the said unit.

Smruthi Organics is a mid-size, public limited, API manufacturing company from Solapur, India. Its core competency is multi-step organic synthesis and large-scale manufacturing of organic molecules.